Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
$13.33
+1.5%
$14.99
$12.10
▼
$24.47
$1.44B0.522.26 million shs1.31 million shs
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$228.83
+1.4%
$253.56
$186.25
▼
$566.47
$6.89B1.53519,881 shs372 shs
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
$13.30
+2.2%
$9.57
$5.11
▼
$14.14
$1.04B0.881.71 million shs22,184 shs
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$7.66
+2.4%
$11.27
$2.08
▼
$15.37
$3.47B0.8815.55 million shs41,472 shs
Novavax, Inc. stock logo
NVAX
Novavax
$8.11
+1.9%
$10.41
$6.20
▼
$13.39
$1.32B2.655.23 million shs23,252 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
-2.45%-6.61%-6.28%-34.05%-36.69%
Dycom Industries, Inc. stock logo
DY
Dycom Industries
+2.20%-0.77%-11.01%-43.74%-23.65%
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
-4.90%-5.93%+60.82%+64.48%+59.63%
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
-0.66%-7.54%-47.36%-16.80%+206.56%
Novavax, Inc. stock logo
NVAX
Novavax
0.00%-20.24%-26.43%-5.46%+21.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
$13.33
+1.5%
$14.99
$12.10
▼
$24.47
$1.44B0.522.26 million shs1.31 million shs
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$228.83
+1.4%
$253.56
$186.25
▼
$566.47
$6.89B1.53519,881 shs372 shs
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
$13.30
+2.2%
$9.57
$5.11
▼
$14.14
$1.04B0.881.71 million shs22,184 shs
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$7.66
+2.4%
$11.27
$2.08
▼
$15.37
$3.47B0.8815.55 million shs41,472 shs
Novavax, Inc. stock logo
NVAX
Novavax
$8.11
+1.9%
$10.41
$6.20
▼
$13.39
$1.32B2.655.23 million shs23,252 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
-2.45%-6.61%-6.28%-34.05%-36.69%
Dycom Industries, Inc. stock logo
DY
Dycom Industries
+2.20%-0.77%-11.01%-43.74%-23.65%
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
-4.90%-5.93%+60.82%+64.48%+59.63%
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
-0.66%-7.54%-47.36%-16.80%+206.56%
Novavax, Inc. stock logo
NVAX
Novavax
0.00%-20.24%-26.43%-5.46%+21.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
1.90
Reduce$17.1730.74% Upside
Dycom Industries, Inc. stock logo
DY
Dycom Industries
2.77
Moderate Buy$502.92122.56% Upside
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
2.63
Moderate Buy$11.80-9.30% Downside
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
2.71
Moderate Buy$13.8084.49% Upside
Novavax, Inc. stock logo
NVAX
Novavax
2.33
Hold$13.6070.85% Upside

Current Analyst Ratings Breakdown

Latest IOVA, ALKT, GDYN, NVAX, and DY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/13/2026
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
UpgradeSell (D) ➝ Hold (C-)
11/13/2026
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
Initiated CoverageEqual Weight$15.00
11/13/2026
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
UpgradeHold ➝ Strong-Buy
11/6/2026
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
Boost Price TargetOverweight$18.00 ➝ $19.00
11/6/2026
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
Boost Price TargetMarket Outperform$8.00 ➝ $12.00
11/6/2026
Novavax, Inc. stock logo
NVAX
Novavax
Reiterated RatingBuy$18.00 ➝ $16.00
11/3/2026
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
Boost Price TargetNeutral$7.00 ➝ $8.00
11/2/2026
Novavax, Inc. stock logo
NVAX
Novavax
Reiterated RatingSell (D)
10/30/2026
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
Boost Price TargetBuy$10.00 ➝ $15.00
10/30/2026
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
Boost Price TargetOverweight$8.00 ➝ $11.00
10/30/2026
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
Boost Price TargetBuy$9.00 ➝ $13.00
(Data available from 11/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
$511.68M2.75N/AN/A$3.36 per share3.91
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$6.88B0.99$22.11 per share10.22$64.21 per share3.52
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
$432.71M2.42$0.39 per share33.53$6.52 per share2.00
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$263.50M13.13N/AN/A$1.76 per share4.25
Novavax, Inc. stock logo
NVAX
Novavax
$411.65M3.19$3.51 per share2.27($1.31) per share-6.08
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
-$47.65M-$0.34N/A28.54N/A-7.24%-4.75%-2.07%N/A
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$281.19M$10.9920.5611.900.384.79%25.30%8.39%11/24/2026 (Estimated)
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
$9.67M$0.09144.5646.46N/A1.81%3.24%2.83%N/A
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
-$390.98M-$0.53N/AN/AN/A-58.20%-29.71%-23.55%N/A
Novavax, Inc. stock logo
NVAX
Novavax
$440.30M-$0.46N/AN/AN/A-18.64%-14.82%-7.55%N/A

Latest IOVA, ALKT, GDYN, NVAX, and DY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/24/2026Q3 2027
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$4.59N/AN/AN/A$1.95 billionN/A
11/5/2026Q3 2026
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
-$0.09-$0.05+$0.04-$0.05$115.98 million$121.47 million
11/5/2026Q3 2026
Novavax, Inc. stock logo
NVAX
Novavax
-$0.3460-$0.19+$0.1560-$0.19$50.42 million$68.30 million
10/29/2026Q3 2026
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
$0.1252$0.18+$0.0548$0.08$112.77 million$114.29 million
10/28/2026Q3 2026
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
$0.1967-$0.06-$0.2567-$0.06$133.54 million$134.91 million
8/26/2026Q2 2027
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$4.72$5.29+$0.57$3.81$1.98 billion$2.01 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
N/AN/AN/AN/AN/A
Dycom Industries, Inc. stock logo
DY
Dycom Industries
N/AN/AN/AN/AN/A
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
N/AN/AN/AN/AN/A
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
N/AN/AN/AN/AN/A
Novavax, Inc. stock logo
NVAX
Novavax
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
0.99
2.04
2.04
Dycom Industries, Inc. stock logo
DY
Dycom Industries
1.35
2.35
2.24
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
N/A
7.34
7.34
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
N/A
5.20
4.67
Novavax, Inc. stock logo
NVAX
Novavax
N/A
2.15
2.09

Institutional Ownership

CompanyInstitutional Ownership
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
54.97%
Dycom Industries, Inc. stock logo
DY
Dycom Industries
98.33%
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
71.18%
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
77.03%
Novavax, Inc. stock logo
NVAX
Novavax
53.04%

Insider Ownership

CompanyInsider Ownership
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
17.10%
Dycom Industries, Inc. stock logo
DY
Dycom Industries
1.22%
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
7.50%
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
7.80%
Novavax, Inc. stock logo
NVAX
Novavax
1.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alkami Technology, Inc. stock logo
ALKT
Alkami Technology
1,225107.04 million88.74 millionOptionable
Dycom Industries, Inc. stock logo
DY
Dycom Industries
19,55630.16 million29.79 millionOptionable
Grid Dynamics Holdings, Inc. stock logo
GDYN
Grid Dynamics
4,96180.37 million74.34 millionOptionable
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
975462.65 million426.57 millionOptionable
Novavax, Inc. stock logo
NVAX
Novavax
749165.01 million162.37 millionOptionable

Recent News About These Companies

Novavax (NASDAQ:NVAX) Shares Down 9.4% - What's Next?
Novavax (NVAX) stock trades up, here is why
Novavax (NASDAQ:NVAX) Upgraded at Wall Street Zen
Novavax Earnings Call Signals Stronger Growth Ahead
Novavax Q3 Earnings Call Highlights
Novavax pushes profitability target to 2029, shares dip

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alkami Technology stock logo

Alkami Technology NASDAQ:ALKT

$13.33 +0.20 (+1.53%)
As of 09:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Alkami Technology, Inc. offers cloud-based digital banking solutions in the United States. The company's Alkami Platform allows financial institutions to onboard and engage new users, accelerate revenues, and enhance operational efficiency, with the support of a proprietary, cloud-based, and multi-tenant architecture. It serves community, regional, super-regional credit unions, and banks. The company was founded in 2009 and is headquartered in Plano, Texas.

Dycom Industries stock logo

Dycom Industries NYSE:DY

$228.83 +3.05 (+1.35%)
As of 09:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Dycom Industries, Inc. provides specialty contracting services to the telecommunications infrastructure and utility industries in the United States. The company offers engineering services to telecommunications providers, including the planning and design of aerial, underground, and buried fiber optic, copper, and coaxial cable systems; wireless networks in connection with the deployment of macro cell and new small cell sites; and program and project management and inspection personnel. It also provides construction, maintenance, and installation services for telephone companies and cable multiple system operators, such as placement and splicing of copper, fiber, and coaxial cables; tower construction, lines and antenna installation, foundation and equipment pad construction, and small cell site placement for wireless carriers, as well as equipment installation and material fabrication, and site testing services; underground facility locating services comprising locating telephone, cable television, power, water, sewer, and gas lines; installation and maintenance of customer premise equipment, including digital video recorders, set top boxes, and modems for cable system operators; and construction and maintenance services for electric and gas utilities, and other customers. Dycom Industries, Inc. was incorporated in 1969 and is headquartered in Palm Beach Gardens, Florida.

Grid Dynamics stock logo

Grid Dynamics NASDAQ:GDYN

$13.30 +0.29 (+2.22%)
As of 09:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Grid Dynamics Holdings, Inc., together with its subsidiaries, provides technology consulting, platform and product engineering, and analytics services in North America, Europe, and internationally. It offers cloud platform and product engineering services, such as architecting, designing, and building scalable and secure cloud-based platforms and business applications; and AI/machine learning and data platform engineering services that build platforms to facilitate batch and streaming data ingestion, quality governance, orchestration, semantic modeling, observability, and analysis at scale. The company provides digital engagement services, including digital ecosystem design and implementation; and supply chain, Internet of Thing, and advanced manufacturing, which focuses on transforming traditional operations into smart and connected ecosystems. It serves customers that operate in the tech, media, telecommunications, retail, consumer packaged goods, manufacturing, and finance industries. The company was formerly known as ChaSerg Technology Acquisition Corp. and changed its name to Grid Dynamics Holdings, Inc. Grid Dynamics Holdings, Inc. was founded in 2006 and is headquartered in San Ramon, California.

Iovance Biotherapeutics stock logo

Iovance Biotherapeutics NASDAQ:IOVA

$7.66 +0.18 (+2.41%)
As of 09:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

Novavax stock logo

Novavax NASDAQ:NVAX

$8.11 +0.15 (+1.86%)
As of 09:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.